The effects of intramuscular interferon beta-Ia in patients at high risk for development of multiple sclerosis: A post hoc analysis of data from CHAMPS

Author： O'Connor P.  

Publisher： Elsevier

ISSN： 0149-2918

Source： Clinical Therapeutics, Vol.25, Iss.11, 2003-11, pp. : 2865-2874

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Appropriate Use of Interferon Beta-1a in Multiple Sclerosis

By Jacobs L.   Brownscheidle C.M.  

BioDrugs, Vol. 11, Iss. 3, 1999-03 ,pp. : 155-163

Adis International

Access to resources Recommend Favorite

Effects of rosiglitazone maleate when added to a sulfonylurea regimen in patients with type 2 diabetes mellitus and mild to moderate renal impairment: A post hoc analysis

By Agrawal A.   Sautter M.C.   Jones N.P.  

Clinical Therapeutics, Vol. 25, Iss. 11, 2003-11 ,pp. : 2754-2764

Elsevier

Access to resources Recommend Favorite

Infectious risk stratification in multiple sclerosis patients receiving immunotherapy

By  

Annals Of Clinical And Translational Neurology, Vol. 4, Iss. 12, 2017-12 ,pp. : 909-914

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of inpatient rehabilitation in multiple sclerosis patients with moderate disability

By Vikman T.   Fielding P.   Lindmark B.   Fredrikson S.  

Advances in Physiotherapy, Vol. 10, Iss. 2, 2008-01 ,pp. : 58-65

Informa Healthcare

Access to resources Recommend Favorite

Spotlight on Subcutaneous Recombinant Interferon- -1a (Rebif ® ) in Relapsing-Remitting Multiple Sclerosis

By Murdoch David   Lyseng-Williamson Katherine A.  

BioDrugs, Vol. 19, Iss. 5, 2005-01 ,pp. : 323-325

Adis International

Access to resources Recommend Favorite